These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16804776)

  • 1. [Reduction of corneal permeability in patients treated with HP-guar: a fluorophotometric study].
    Cerván-López I; Sáenz-Francés-San-Baldomero F; Benítez-Del-Castillo JM; García-Sánchez J
    Arch Soc Esp Oftalmol; 2006 Jun; 81(6):327-32. PubMed ID: 16804776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.
    Ubels JL; Clousing DP; Van Haitsma TA; Hong BS; Stauffer P; Asgharian B; Meadows D
    Curr Eye Res; 2004 Jun; 28(6):437-44. PubMed ID: 15512952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of artificial tears on corneal epithelial permeability in dry eyes.
    Göbbels M; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(4):345-9. PubMed ID: 1916322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of artificial tears on corneal epithelium in dry-eye syndrome.
    Göbbels M; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):139-41. PubMed ID: 2721982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears.
    Göbbels M; Spitznas M
    Ophthalmology; 1992 Jun; 99(6):873-8. PubMed ID: 1630776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
    Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease.
    Fahim MM; Haji S; Koonapareddy CV; Fan VC; Asbell PA
    BMC Ophthalmol; 2006 May; 6():20. PubMed ID: 16729882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubricant with gelling agent in treating dry eye in adult Chinese patients.
    Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L
    Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye.
    Dienes L; Kiss HJ; Perényi K; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
    PLoS One; 2015; 10(8):e0135629. PubMed ID: 26302222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium.
    Rangarajan R; Ketelson H
    J Ocul Pharmacol Ther; 2019; 35(1):32-37. PubMed ID: 30489200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atelocollagen punctal occlusion in dry eye patients.
    Miyata K; Otani S; Miyai T; Nejima R; Amano S
    Cornea; 2006 Jan; 25(1):47-50. PubMed ID: 16331041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal epithelial permeability and dry eye treatment.
    Benitez-del-Castillo JM; Aranguez C; Garcia-Sanchez J
    Adv Exp Med Biol; 2002; 506(Pt A):703-6. PubMed ID: 12613980
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal permeability changes in dry eye disease: an observational study.
    Fujitani K; Gadaria N; Lee KI; Barry B; Asbell P
    BMC Ophthalmol; 2016 May; 16(1):53. PubMed ID: 27177442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal metabolism and epithelial barrier function after cataract surgery and intraocular lens implantation: a fluorophotometric study.
    Lohmann AM; van Best JA; de Keizer RJ
    Int Ophthalmol; 1995-1996; 19(4):225-33. PubMed ID: 8737703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.
    Yokoi N; Komuro A; Nishida K; Kinoshita S
    Br J Ophthalmol; 1997 Jul; 81(7):533-6. PubMed ID: 9290362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye.
    Springs CL
    Adv Ther; 2010 Oct; 27(10):681-90. PubMed ID: 20803266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium compound protects corneal epithelium against oxidative stress.
    Higuchi A; Inoue H; Kawakita T; Ogishima T; Tsubota K
    PLoS One; 2012; 7(9):e45612. PubMed ID: 23049824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops.
    Schrage N; Frentz M; Spoeler F
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1333-40. PubMed ID: 22580989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.